165 related articles for article (PubMed ID: 689212)
1. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
Tanae A; Shimizu K; Yoshida S
Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
[TBL] [Abstract][Full Text] [Related]
2. [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
Tomita M; Nakagawa S; Saito N; Sakurada N; Nonoda A
Horumon To Rinsho; 1979 Jun; 27(6):681-5. PubMed ID: 466837
[No Abstract] [Full Text] [Related]
3. [Effects of vasopressin analogue DDAVP in patients with postoperative diabetes insipidus (author's transl)].
Kubota T; Kashiwara K; Ito H; Tani K; Yamamoto S
No To Shinkei; 1981 Jun; 33(3):617-23. PubMed ID: 7259900
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
Kosman ME
JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
Lee WP; Lippe BM; La Franchi SH; Kaplan SA
Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
[TBL] [Abstract][Full Text] [Related]
7. [Long-term experience with 1-deamino-8-D-arginin vasopressin (DDAVP) treatment of children with diabetes insipidus centralis (author's transl)].
Némethová V; Lichardus B; Lehotská V
Bratisl Lek Listy; 1979 Feb; 71(2):217-24. PubMed ID: 427617
[No Abstract] [Full Text] [Related]
8. Ten-year experience with DDAVP in treatment of diabetes insipidus.
Marek J; Loutocký A; Pacovský V; Zaoral M
Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
[TBL] [Abstract][Full Text] [Related]
9. Neurogenic diabetes insipidus: management with dDAVP (1-desamino-8-D arginine vasopressin).
Cobb WE; Spare S; Reichlin S
Ann Intern Med; 1978 Feb; 88(2):183-8. PubMed ID: 626447
[TBL] [Abstract][Full Text] [Related]
10. [DDAVP in the treatment of acute neurosurgical diabetes insipidus].
Zancaner F; Griner A; Galante E
Minerva Med; 1984 Apr; 75(18):1063-7. PubMed ID: 6728257
[TBL] [Abstract][Full Text] [Related]
11. [Pseudoresistance to DDAVP in diabetes insipidus].
Radó J; Pató E; Czigner J; Fáber K
Orv Hetil; 1985 Aug; 126(33):2043-6. PubMed ID: 4034192
[No Abstract] [Full Text] [Related]
12. Postcraniotomy diabetes insipidus: treatment with DDAVP, a synthetic analog of vasopressin.
Daneman D; Ehrlich RM; Bailey JD
J Pediatr; 1978 Nov; 93(5):879-80. PubMed ID: 712500
[No Abstract] [Full Text] [Related]
13. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
Blackett PR; Seely JR; Altmiller DH; Males JL
Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
[TBL] [Abstract][Full Text] [Related]
14. [Diabetes insipidus--with special reference to DDAVP therapy].
Shimizu K
Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
[No Abstract] [Full Text] [Related]
15. DDAVP in the treatment of central diabetes insipidus.
Robinson AG
N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
[TBL] [Abstract][Full Text] [Related]
16. [Treatment and effects of desmopressin (DDAVP) in patients with central diabetes insipidus (author's transl)].
Matsui K; Kimura T; Ota K; Iitake K; Yoshinaga K
Horumon To Rinsho; 1979 Aug; 27(8):891-5. PubMed ID: 487624
[No Abstract] [Full Text] [Related]
17. [Long-term treatment of central diabetes insipidus with oral DDAVP].
Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
Radó JP; Marosi J; Fischer J
Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
[TBL] [Abstract][Full Text] [Related]
19. [Schwartz-Bartter syndrome following long-term DDAVP therapy in a patient with diabetes insipidus].
Radó J; Pató E
Orv Hetil; 1983 May; 124(22):1323-6. PubMed ID: 6877810
[No Abstract] [Full Text] [Related]
20. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
Lebacq E; David L
Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
